Search / 5 results found

from
to
AP
  • Updated

Hillary Clinton returned to the Southern California hospital where Bill Clinton is being treated for an infection. She returned around 8 a.m. Saturday in an SUV accompanied by secret service agents. President Joe Biden says Bill Clinton is doing fine and will be released soon. Biden said Friday that he'd spoken with the former president and he's not “in any serious condition." A spokesman for Clinton had said he was being held overnight Friday to receive antibiotics. Bill Clinton, who's 75, was admitted to a hospital in Orange County on Tuesday for what an aide says was a urological infection that spread to his bloodstream. 

  • Updated

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine. And a new study raises the prospect that using a different vaccine might give a better boost. On Thursday and Friday, an FDA advisory panel will recommend whether to back boosters of both the J&J and Moderna vaccines. In a review posted Wednesday, FDA scientists didn’t reach a firm conclusion on J&J booster doses, citing shortcomings with the company's data. An extra dose of Pfizer’s vaccine already is available to certain Americans.

  • Updated

Texas Gov. Greg Abbott issued an executive order Monday to prohibit any entity, including private business, from enforcing a COVID-19 vaccine mandate on workers and called on state lawmakers to pass a similar ban into law. The Republican previously sought to ban state and local governments from enforcing a ban but had not stepped into rules businesses set for their workers. It was not immediately clear if the latest order would face a quick court challenge. Texas has seen a recent decrease in new COVID-19 cases and hospitalizations. But a rising death toll from the recent surge caused by the delta variant has the state rapidly approaching 67,000 total fatalities.

  • Updated

Drugmaker Merck has asked U.S. regulators to authorize its promising antiviral pill against COVID-19, setting the stage for a decision within weeks. If cleared by the Food and Drug Administration, it would be the first pill shown to treat COVID-19, adding a new, easy-to-use weapon to the world's arsenal against the pandemic. The FDA will scrutinize company data on the drug’s safety and effectiveness before rendering a decision. All COVID-19 drugs now authorized by the FDA require an IV or injection.

  • Updated

Drugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus. The company said Friday that it would soon ask health officials in the U.S. and around the world to authorize its use. The drug would be the first pill shown to treat COVID-19. That is a potentially major advance in efforts to fight the pandemic. The study results were released by the company and have not been peer reviewed. An independent group of medical advisers monitoring the trial recommended stopping it early because the interim results were so strong.